ChronoScale Corporation reported $28M of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $28M (to Q3 2026). Net income: −$27M, trailing twelve months to Q3 2026. Free cash flow: −$13M, trailing twelve months to Q3 2026. Operating margin: −155%, trailing twelve months to Q1 2027.

CHRNChronoScale Corporation

Technology

$14.78+201% 1Y

$14.78

$3.8752 weeks$29.82

Latest close: below its 200-day averageOct 23, 2026what changed →

CHRN as reported

ChronoScale Corporation reported $28M of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed.

$28M

Revenue, trailing twelve months · to Q3 2026 · every figure below is as filed, with no scoring applied

Net income: −$27M
Net income · trailing twelve months to Q3 2026
Free cash flow: −$13M
Free cash flow · trailing twelve months to Q3 2026
Operating margin: −155%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for CHRN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$28M	n/a	Q3 2026
Net income	−$27M	n/a	Q3 2026
EPS	−$5.46	n/a	Q3 2026
Gross margin	31%	n/a	Q1 2027
Operating margin	−155%	n/a	Q1 2027
Net margin	−191%	n/a	Q1 2027
ROE	−378%	n/a	Q3 2026
ROA	−42%	n/a	Q2 2025 · 7 quarters behind
ROIC	4597%	n/a	Q1 2027
Free cash flow	−$13M	n/a	Q3 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.